Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 03, 2020 / NTS GMT
Release Date Price: $50.97 (-0.66%)
Tyler Martin Van Buren
Piper Sandler & Co., Research Division - Principal & Senior Biotech Analyst

Hi there, everyone. My name is Tyler Van Buren, I'm a senior biotech analyst at Piper Sandler. Welcome to Piper's 32nd Annual Healthcare Conference. As this is our first time with a virtual format, we appreciate you all logging in. For this session, we're very pleased to have Ionis Pharmaceuticals here with us. And from Ionis, we have Brett Monia, the Chief Executive Officer; and Beth Hougen, the Chief Financial Officer.

So I figured we could start with a brief state of the union of the company and the description of the science behind the drugs for those who are less familiar, which by now, I'm sure it's not many. But also, it would be helpful to explain why you guys are so committed to the antisense technology and what indications it could be used for.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Sure. Thank you very much, Tyler, and thank you for the invitation. It's a pleasure to be here. So yes, we're very excited

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot